Andrews N - Search Results

1

Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years.

Asturias EJ, Wharton M, Pless R, MacDonald NE, Chen RT, Andrews N, Salisbury D, Dodoo AN, Hartigan-Go K, Zuber PL. Asturias EJ, et al. Among authors: andrews n. Vaccine. 2016 Jun 17;34(29):3342-9. doi: 10.1016/j.vaccine.2016.05.018. Epub 2016 May 16. Vaccine. 2016. PMID: 27195758 Free PMC article. Review.

2

Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales.

Andrews NJ, Waight PA, George RC, Slack MP, Miller E. Andrews NJ, et al. Vaccine. 2012 Nov 6;30(48):6802-8. doi: 10.1016/j.vaccine.2012.09.019. Epub 2012 Sep 18. Vaccine. 2012. PMID: 23000122

3

Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.

van Hoek AJ, Sheppard CL, Andrews NJ, Waight PA, Slack MP, Harrison TG, Ladhani SN, Miller E. van Hoek AJ, et al. Among authors: andrews nj. Vaccine. 2014 Jul 23;32(34):4349-55. doi: 10.1016/j.vaccine.2014.03.017. Epub 2014 Mar 21. Vaccine. 2014. PMID: 24657717

4

Near real-time vaccine safety surveillance using electronic health records-a systematic review of the application of statistical methods.

Leite A, Andrews NJ, Thomas SL. Leite A, et al. Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):225-37. doi: 10.1002/pds.3966. Epub 2016 Jan 28. Pharmacoepidemiol Drug Saf. 2016. PMID: 26817940 Free PMC article. Review.

5

Implementing near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD).

Leite A, Thomas SL, Andrews NJ. Leite A, et al. Vaccine. 2017 Dec 14;35(49 Pt B):6885-6892. doi: 10.1016/j.vaccine.2017.09.022. Epub 2017 Oct 19. Vaccine. 2017. PMID: 29056424 Free article.

6

School-based vaccination programmes: An evaluation of school immunisation delivery models in England in 2015/16.

Tiley K, Tessier E, White JM, Andrews N, Saliba V, Ramsay M, Edelstein M. Tiley K, et al. Among authors: andrews n. Vaccine. 2020 Mar 30;38(15):3149-3156. doi: 10.1016/j.vaccine.2020.01.031. Epub 2020 Jan 21. Vaccine. 2020. PMID: 31980192

7

Immunogenicity and reactogenicity of acellular diphtheria/tetanus/pertussis vaccines given as a pre-school booster: effect of simultaneous administration of MMR.

Miller E, Waight P, Laurichesse H, Andrews N, Thornton C, Sesardic D, Corbel M. Miller E, et al. Among authors: andrews n. Vaccine. 2001 Jul 16;19(28-29):3904-11. doi: 10.1016/s0264-410x(01)00123-2. Vaccine. 2001. PMID: 11427264 Clinical Trial.

8

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox.

Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Brisson M, et al. Among authors: andrews nj. Vaccine. 2002 Jun 7;20(19-20):2500-7. doi: 10.1016/s0264-410x(02)00180-9. Vaccine. 2002. PMID: 12057605

9

Sero-epidemiology of Bordetella pertussis in England and Wales.

Nardone A, Pebody RG, Maple PA, Andrews N, Gay NJ, Miller E. Nardone A, et al. Among authors: andrews n. Vaccine. 2004 Mar 12;22(9-10):1314-9. doi: 10.1016/j.vaccine.2003.08.039. Vaccine. 2004. PMID: 15003661

10

Laboratory methods for assessing vaccine potency retained in aerosol outputs from nebulizers: application to World Health Organization measles aerosol project.

Cohen BJ, Parry RP, Andrews N, Bennett AM, Dennis JH. Cohen BJ, et al. Among authors: andrews n. Vaccine. 2008 Jun 25;26(27-28):3534-9. doi: 10.1016/j.vaccine.2008.04.027. Epub 2008 May 2. Vaccine. 2008. PMID: 18490082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,300 results

Search Page

Filters